Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer Group.
Bamias A, Koutsoukos K, Gavalas N, Zakopoulou R, Tzannis K, Dedes N, Boulouta A, Fragkoulis C, Kostouros E, Dellis A, Mitsogiannis I, Adamakis I, Anastasiou I, Skolarikos A, Papatsoris A, Stravodimos K, Ferakis N, Pagoni S, Ntoumas K, Mitropoulos D, Deliveliotis C, Constantinides CA, Dimopoulos MA. Bamias A, et al. Among authors: boulouta a. Curr Oncol. 2021 Nov 5;28(6):4474-4484. doi: 10.3390/curroncol28060380. Curr Oncol. 2021. PMID: 34898581 Free PMC article.
Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019.
Tziolos N, Karofylakis E, Grigoropoulos I, Kazakou P, Koullias E, Savva A, Kranidioti H, Pelekanou A, Boulouta A, Pirounaki M, Tsiodras S, Georgiopoulos G, Boumpas DT, Kavatha D, Thomas K, Vassilopoulos D, Antoniadou A. Tziolos N, et al. Among authors: boulouta a. Open Forum Infect Dis. 2021 Nov 22;9(1):ofab588. doi: 10.1093/ofid/ofab588. eCollection 2022 Jan. Open Forum Infect Dis. 2021. PMID: 34988257 Free PMC article.
The impact of metabolic health on non-alcoholic fatty liver disease (NAFLD). A single center experience.
Boulouta A, Aggeletopoulou I, Kanaloupitis S, Tsounis EP, Issaris V, Papantoniou K, Apostolos A, Tsaplaris P, Pastras P, Sotiropoulos C, Tsintoni A, Diamantopoulou G, Thomopoulos K, Michalaki M, Triantos C. Boulouta A, et al. Clin Res Hepatol Gastroenterol. 2022 May;46(5):101896. doi: 10.1016/j.clinre.2022.101896. Epub 2022 Feb 25. Clin Res Hepatol Gastroenterol. 2022. PMID: 35227957
Well-differentiated liposarcomas and dedifferentiated liposarcomas: Systemic treatment options for two sibling neoplasms.
Kyriazoglou A, Pagkali A, Kotsantis I, Economopoulou P, Kyrkasiadou M, Moutafi M, Gavrielatou N, Anastasiou M, Boulouta A, Pantazopoulos A, Giannakakou M, Digklia A, Psyrri A. Kyriazoglou A, et al. Among authors: boulouta a. Cancer Treat Rev. 2024 Apr;125:102716. doi: 10.1016/j.ctrv.2024.102716. Epub 2024 Mar 11. Cancer Treat Rev. 2024. PMID: 38492514 Review.
Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm.
Bamias A, Zakopoulou R, Tzannis K, Sakellakis M, Koutsoukos K, Kyriazoglou A, Panagiotou A, Armylagos S, Rokas K, Gotzias D, Boulouta A, Bozionelou V, Stravodimos K, Varkarakis I, Mavroudis D, Dimopoulos MA. Bamias A, et al. Among authors: boulouta a. Anticancer Drugs. 2023 Mar 1;34(3):413-421. doi: 10.1097/CAD.0000000000001420. Epub 2022 Nov 16. Anticancer Drugs. 2023. PMID: 36730619 Clinical Trial.